Allurion Technologies, Inc. (NYSE: ALUR) has announced new study results showing an average weight reduction of 10.5% at four months, improving to 13.7% at one year with the Allurion Program. This data highlights that not only can weight loss be maintained using the program, but it can also be enhanced with its ongoing virtual guidance and support.
The study involved 486 patients from a major bariatric center, who used the Allurion Balloon and were monitored monthly with the Allurion App, Connected Scale, and Health Tracker. Over a year, participants received virtual consultations from registered dieticians, starting with weekly check-ups, transitioning to biweekly, and then monthly.
Dr. Nik Ritza Kosai, Associate Professor at The National University of Malaysia and lead author of the study, commented, “This is the largest study of its kind in Southeast Asia. Our results demonstrate that the swallowable gastric balloon is effective for weight loss and maintenance. The combination of the balloon and a year of virtual support significantly enhances weight loss outcomes.”
In contrast, other weight loss methods, such as GLP-1 drugs, have shown that patients typically regain about two-thirds of their lost weight after discontinuation.
Dr. Ram Chuttani, Chief Medical Officer of Allurion, added, “While significant weight loss is usually seen within the first four months with the Allurion Balloon, this study shows that extending support through a 12-month virtual program significantly improves outcomes even after the balloon is removed.”
About Allurion
Allurion aims to end obesity with its innovative weight loss platform, including the Allurion Gastric Balloon—the world’s first swallowable, procedure-less intragastric balloon. The Allurion Program also offers the Allurion Virtual Care Suite, featuring a mobile app, insights for healthcare providers, and a connected scale. The program is designed to enhance weight loss through a combination of device use and virtual support. The Allurion Gastric Balloon remains an investigational device in the United States.
